We would love to hear your thoughts about our site and services, please take our survey here.
Whilst pure speculation on my part; I would not be the least bit surprised if the licencing deal announced today by Sareum Holdings plc with a US Private Equity Company didn't actually involve Nick Glover being somewhere in the mix (i.e. the ex CEO of ProNAi Therapeutics and Sierra Oncology) and if so, then this is indeed fantastic news for Sareum shareholders, as no one is more acutely aware and intimately informed of SRA737's multi-applicable disease targeting properties and potential than is Nick Glover and his drive, focus and passion in progressing this compound with the utmost haste is precisely what is now required.
Nice to be proven wrong about 737
GLA
Laz it’s also the lack of shares which is hindering the sp if you have big investors who want in and they carnt get them shares they move on im sure most of the shares held are probably LTH s and not many are going to let go especially at this price since consolidation what has been the biggest buy you ve seen ?
Laz when I asked the question about 1802 and they gave the answer I was disappointed to say the least my impression is we don’t have the funds to progress it not unless something appears from 737 which again over a year and nothing everything imho is hinging on 1801, why we carnt get someone on board to help progress 1802 is beyond me as I believe it is the biggest earner anything related to Cancer and first in class would attract investment but on a positive note we have gone blue
GLA for 2024
Https://www.mckinsey.com/industries/healthcare/our-insights/2024-jp-morgan-healthcare-conference-and-mckinsey
Let’s hope we can come away with something from this would be a good start to the year
GLA
Fearg the general consensus is the SP should be higher and I’m sure there will be funding available on release of good news as been said it’s the data that will drive us up news could drop anytime now ref the end of Phla completion and also interesting liquidity or lack of is a factor strangling the SP so maybe we will need to release more shares to achieve this just mho
GLA
Carter everyone is entitled to their opinion but as long as your happy with decisions made that’s fine I and I’m sure plenty others arnt and if I want to hold people accountable for their decisions which have failed then I will do last year the board imho got of lightly and the way they got out of it was the 737 comment and jumping around like excited school boys which believe it or not has yes come to nothing 3 days to prove investors wrong if not then I believe a change needs to happen and the buck stops with the chairman . Hopefully see you at the AGM and have a beer after
GLA
Https://www.proactiveinvestors.co.uk/companies/news/21457/sareum-holdings-an-early-stage-drug-group-with-a-very-interesting-future--25583.html
Carter I’ve only been here over 10 years but interesting to note from the above they seized on fund raising when the price was high yet this time never . Yes I bang on about consolidation , peel hunt and misleading quotes I wonder why .I also knew the average cost was 1B to take a drug to market so yes I do get frustrated when opertunitys have been missed by a so called expert as I’ve said before if no news landed by the day of the AGM I will be calling for a vote of confidence in Parker and asking why he should be sat where he is after a near 85pc decline in sp
We did need ph1 data and again I concur misleading information from Parker and I hope there will be a few at the AGM to not let the latest form an orderly. Cue comment to just be brushed off
GLA